| LATEST NEWS | PM Anwar Ibrahim arrives in Ashgabat at 8 pm local time (11 pm Malaysian time) for a two-day official visit to Turkmenistan | Federal Government Approves Establishment of National Tahfiz Council - Ahmad Zahid | Johor Polls: Chu Poh Yee named DAP candidate for Mengkibol state seat, replacing Chew Chong Sin - Loke | Oil supply: The draft agreement and cooperation principles have been agreed upon; only the finalisation and signing remain after a detailed technical visit – PM Anwar | Malaysia's improved 2026 World Competitiveness Ranking reflects focus on efficiency, determination - PM Anwar | |
KUALA LUMPUR, June 18 (Bernama) -- National reinsurer Malaysian Reinsurance Bhd (Malaysian Re) and China Reinsurance Life Insurance Company Ltd (China Re Life) have signed a landmark reinsurance treaty to support the first dedicated reinsurance framework for cancer precision medicine (CPM) treatment coverage in Malaysia.
KUALA LUMPUR, June 8 (Bernama) -- Dark Horse Consulting Group (DHCG) has signed a memorandum of understanding (MoU) with Altruist Biologics to establish a strategic collaboration aimed at accelerating the development and global commercialisation of biologic therapies.
KUALA LUMPUR, May 28 (Bernama) -- Mevion Medical Systems has signed a definitive purchase agreement with Tam Anh General Hospital to supply the MEVION S250-FIT Proton Therapy System, marking what is expected to become Vietnam’s first proton therapy system.
KUALA LUMPUR, May 26 (Bernama) -- AGC Biologics has been selected by Teikoku Seiyaku Co Ltd to provide microbial contract development and manufacturing services for KTP-001, a recombinant human matrix metalloproteinase-7 (rhMMP-7) therapy being developed to treat lumbar disc herniation.
KUALA LUMPUR, May 12 (Bernama) -- Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and Development (Beijing) Co Ltd (KunTuo) signed a memorandum of understanding to establish a strategic collaboration supporting biotherapeutics developers conducting clinical trials in China.
KUALA LUMPUR, April 28 (Bernama) -- AGC Biologics, a global biopharmaceutical contract development and manufacturing organisation (CDMO), has won the 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance.
KUALA LUMPUR, April 28 (Bernama) -- Dark Horse Consulting Group (DHCG) has signed a memorandum of understanding (MoU) with Porton Advanced to establish a strategic collaboration aimed at accelerating the development and clinical translation of cell and gene therapies globally.
KUALA LUMPUR, March 4 (Bernama) -- Cirrus Therapeutics, a global ocular immunology company, announced several business and pipeline updates to support its strategy of advancing first-in-class and best-in-class therapies for chronic blinding diseases.
KUALA LUMPUR, Feb 12 (Bernama) -- The Malaysian Franchise Association (MFA) is targeting an estimated RM600 million in potential investment value from the Franchise International Malaysia (FIM) 2026 exhibition, up from RM424 million recorded last year.
KUALA LUMPUR, Jan 6 (Bernama) -- Helus Pharma, formerly Cybin Inc, marked its transition toward commercialisation as it began trading on the Nasdaq Global Market and Cboe Canada under the ticker symbol HELP, reflecting a strategic rebrand and corporate repositioning.
KUALA LUMPUR, Oct 31 (Bernama) -- Australis Scientific has been named the 2025 MedTech Innovator (MTI) Asia Pacific (APAC) Grand Prize winner, receiving US$175,000 in non-dilutive funding for its smart patch that delivers minimally invasive neuromodulation therapy for overactive bladder. (US$1=RM4.19)
KUALA LUMPUR, Oct 30 (Bernama) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) will open Saudi Arabia’s first facility for manufacturing genetic and cellular therapies by late 2025, a move set to transform patient care and the nation’s biotech landscape.
